RIGOSERTIB
associated with 13 other trademarks
pharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematolog...

Words that describe this trademark:

pharmaceuticals drugs  cancer pancreatic  ovarian cancer  pancreatic cancers  drugs treatment  treatment cancer  myelodysplastic syndromes  cancers  cancer  syndromes 

Serial Number:

85871317

Mark:

RIGOSERTIB

Status:

Abandoned-After Publication

Status Date:

07-23-2013

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

pharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematological diseases

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

07-23-2013

Mark Drawing Status:

Standart Character Mark

Abandon Date:

07-10-2013

Business Name:

AARON | SANDERS PLLC

Correspondent Name:

Recent Trademark filings by this company